Cargando…
Gene Mutations Associated With Clinical Characteristics in the Tumors of Patients With Breast Cancer
BACKGROUND: Clinical characteristics including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2) are important biomarkers in the treatment of breast cancer, but how genomic mutations affect their status is rarely studied. This study aimed at finding genom...
Autores principales: | Hao, Chunfang, Wang, Chen, Lu, Ning, Zhao, Weipeng, Li, Shufen, Zhang, Li, Meng, Wenjing, Wang, Shuling, Tong, Zhongsheng, Zeng, Yanwu, Lu, Leilei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046571/ https://www.ncbi.nlm.nih.gov/pubmed/35494043 http://dx.doi.org/10.3389/fonc.2022.778511 |
Ejemplares similares
-
Tumor grade-associated genomic mutations in Chinese patients with non-small cell lung cancer
por: Wang, Yang, et al.
Publicado: (2023) -
Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer
por: Jia, Yan, et al.
Publicado: (2019) -
Cardiac safety analysis of anti-HER2-targeted therapy in early breast cancer
por: Zhang, Li, et al.
Publicado: (2022) -
Real‐world data for the renal safety of abemaciclib combined with bisphosphonate in HR+/HER2− advanced breast cancer
por: Hao, Chunfang, et al.
Publicado: (2022) -
Analysis of Clinical Characteristics, Treatment, and Prognostic Factors of 106 Breast Cancer Patients With Solitary Pulmonary Nodules
por: He, Lihong, et al.
Publicado: (2022)